MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...
As more employees identify as neurodivergent, traditional workplace training is falling short. Eleanor Hecks explores ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback